在药物废水中出现MDR Enterobacter hormaechei RSM5及其对β-lactam抗生素除去废水的影响
Swati Srivastava1, Virendra Singh Rana2, Rajni Singh3
1Amity Institute of Microbial Technology, Amity University, Uttar Pradesh, Sector-125, Noida, 201301, India.
Current microbiology
|February 7, 2025
概括
制药污水含有抗生素耐药的细菌,其中Enterobacter hormaechei RSM5表现出高抗素耐药性并降解了抗生素. 这突出了对公众健康的重大威胁和生物修复的潜力.
科学领域:
- 环境微生物学环境微生物学
- 抗微生物耐药性研究的研究.
- 生物技术是生物技术.
背景情况:
- 抗生素耐药性是一个主要的全球健康威胁,由制药废物加剧.
- 贝塔乳酸抗生素 (BLA) 广泛使用,但对耐药性有显著的贡献.
- 工业废水处理将高度的抗生素引入环境.
研究的目的:
- 为了研究药品废水中的抗生素耐药细菌菌株.
- 描述一种具有高抗素耐药性的多抗药性分离物.
- 探索耐药细菌对抗生素降解的潜力.
主要方法:
- 从制药废水中分离和选细菌菌株.
- 确定安培的最小抑制度 (MICs).
- 鉴定细菌分离物和评估抗生素耐药性概况.
- 高性能液体色谱 (HPLC) 用于抗生素降解分析.
主要成果:
- 在废水中发现了50多种抗生素耐药细菌菌株.
- 肠杆菌hormaechei RSM5表现出高抗素耐药性 (MIC>15,000微克/毫升) 并产生β-乳酸酶.
- 这种多药耐药菌株在24小时内使安皮西林降解了100%.
- 通过HPLC证实了安皮西林被分离物降解.
结论:
- 制药废水是多药耐药细菌的储存库.
- 肠杆菌 hormaechei RSM5 显示出显著的安皮西林耐药性和降解能力.
- 这一发现表明,抗生素污染地区的生物修复有可能发生.
相关概念视频
Antibiotic Selection
52.2K
Overview
52.2K
Bacterial Transformation
55.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.1K


